Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beyer

Showing results (511-520 of 516) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 516 results.
Zeitschrift Fur Gastroenterologie|December 6, 2011
[The clinical spectrum of urea cycle defects in adult patients]Alex Michael Müller-Marbach, V Keitel, T Göbel, et al.
Journal of Medicinal Chemistry|January 18, 2018
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral BioavailabilityJohn T Randolph, A Chris Krueger, Pamela L Donner, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 9, 2026
Guidelines for Evaluating Endothelial Function in Vascular TissueCameron G McCarthy, Christian Aalkjær, Pooneh Bagher, et al.
Journal of Synchrotron Radiation|April 19, 2008
Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034Vincent Madison, Andrew J Prongay, Zhuyan Guo, et al.
Journal of Medicinal Chemistry|April 21, 2007
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimizationAndrew J Prongay, Zhuyan Guo, Nanhua Yao, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 15, 2019
Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery DepartmentsWolfgang von Scheidt, A Welz, M Pauschinger, et al.
Pageof 52

Showing results (511-520 of 516) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 516 results.
Zeitschrift Fur Gastroenterologie|December 6, 2011
[The clinical spectrum of urea cycle defects in adult patients]Alex Michael Müller-Marbach, V Keitel, T Göbel, et al.
Journal of Medicinal Chemistry|January 18, 2018
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral BioavailabilityJohn T Randolph, A Chris Krueger, Pamela L Donner, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 9, 2026
Guidelines for Evaluating Endothelial Function in Vascular TissueCameron G McCarthy, Christian Aalkjær, Pooneh Bagher, et al.
Journal of Synchrotron Radiation|April 19, 2008
Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034Vincent Madison, Andrew J Prongay, Zhuyan Guo, et al.
Journal of Medicinal Chemistry|April 21, 2007
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimizationAndrew J Prongay, Zhuyan Guo, Nanhua Yao, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 15, 2019
Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery DepartmentsWolfgang von Scheidt, A Welz, M Pauschinger, et al.
Pageof 52